Our study aims to reveal the correlation between positive surgical margins and prostate volume, thus determining a cutoff value for the prostate volume to predict PCM in patients with open radical prostatectomy.
Introduction
Radical prostatectomy (RP) in patients with localized prostate cancer is considered the gold standard compared to the other treatment alternatives. Considering the fact that the most useful method in diagnostic and clinical aspects is the one providing us with the best information on stage, grade and surgical margin, this treatment method gives us more precise information. RP is achieved by using any one of three methods including open, laparoscopic and robotic approaches. Although many studies have suggested both the benefits and the disadvantages of each method, there is need for further studies with large series, particularly in robotic surgery. All of these three methods revealed particularly the importance of prostate volume on RP outcomes (1-9). Positive surgical margin (PCM) is a common problem confronted after surgery. The term positive surgical margin refers to a correlation of cancer cells with margins of radical prostatectomy specimens. It is probably a result of an intra-prostatic incision. This usually results from the efforts to leave a longer urethra during apical dissection to preserve its continence or at spacing the neurovascular bundle for the protection of erectile function (10) . The importance of PCM includes higher recurrence rate in these patients during postoperative period and shorterlife expectation (11, 12) . One of the factors affecting PCM is the prostate volume (PV). A few recent studies have pointed out a negative correlation between the PV and the PCM (1, 3, 13). However, a wide range of prostate volumes was assessed in these studies. 
Material and Methods
In our study, a number of 450 patients who had undergone radical prostatectomy surgery at 2 centers within the last 5 years was evaluated. Upon the approval from the ethics committee of our hospital; demographic, radiological and operational data were obtained from the hospital data bank for these patients. On the other hand, pathological data were extracted from the pathology database and archive. Age, total PSA, number of positive cores for prostate cancer, Gleason score, transfusion amount and prostate volume were all evaluated in the study. The Gleason score was assessed according to 2009 International Society of Urology Pathology (ISUP) application. The prostate volume was determined using the formula of ᴨ / 6 x height x width x length for elliptical volume accompanied by transrectal ultrasonography. Any use of nerve-sparing technique or approach was left to the discretion of surgeon and/or institution. All patients underwent open RP by physicians with at least 10 years of experience using the technique described by Walsh. Evaluated all these parameters, 170 consecutive patients of whom data were available were included in the study. Pathological specimens were evaluated in a similar manner at both institutions. Surgical specimens were fixed in 10% formalin. The outer surface of prostate was stained with Indian ink. Samples were collected from seminal vesicles for bladder neck as well as from apex for surgical margins. Sectioning at intervals of 4-5 mm was performed from bladder neck to apex, and these sections were pathologically staged according to the 2002 TNM calcifications.
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY). Continuous variables were tested for normality by the Kolmogorov-Smirnov test. Normally distributed data are presented as means ± standard deviation. The rates and proportions of discrete variables were determined using the chi-squared test. The median with data range (minimum to maximum) was used for non-normally distributed data. The independent-samples t-test and Mann-Whitney U test were used for parametric and nonparametric groups, respectively. For the multivariate analysis, parameters which are significant in the univariate analysis in terms of positive surgical margins were analyzed using logistic regression analysis to determine the independent predictive terms. Results were expressed as odds ratio (OR) and 95% confidence interval (CI). The two-sided p value of <0.05 was considered to indicate statistical significance.
Results
When evaluated 170 patients included in the study, the mean age was 63.3 ± 6.2 for patients with negative surgical margin, whereas it was 63.6 ± 5 for those with positive surgical margins. Compared to those with PSA ≤ 10 ng/dl, the patients with PSA >10 ng/dl demonstrated statistically significant PCM in univariate analysis (p=0,002). The number of positive cores was statistically significantly higher in those with positive surgical margin in transrectal biopsies obtained before radical prostatectomy (p = 0.002). The Gleason score from these biopsies was also statistically higher in those with positive surgical margins (p <0.001). Evaluated the stages again, a statistically significantly higher T3 stage was found in the patient group with positive surgical margin (p <0.001) ( Table 1) . When we performed AUROC analysis to determine the positivity of surgical margin in terms of prostate volume, we achieved a cutoff value of 34.5 with 55% sensitivity and 71% specificity (AUC: 0.646, 95% CI: 0.555 to 0.737, p = 0.002) (Figure 1 ). When we examine the prostate volume at this level, we found the positivity of surgical margin to be statistically significantly higher in patients with prostate volume being equal to or less than 34.5 cc 
Discussion
In our study, there was a significant correlation between the patients with PSA > 10 ng / dL and those in stage T3 to the extent that the positivity of surgical margin increased by 2.67 and 8.51 times, respectively. Likewise, concordant to the current studies, a significant correlation was found between decreased prostate volume and the positivity of surgical margin to increase the risk by 2.86 times.
Positive surgical margins after radical prostatectomy have been reported as 11% to 46% in several studies (14) (15) (16) . Our study suggested this rate as 36.5%. One of the most important factors in the development of local recurrence after RP is the positivity of surgical margins (17, 18) .In a study, the recurrence rate was found 19% in patients with positive surgical margin, whereas it was 7% in those with negative (19) . The nonrecurring rate over 5 years in patients with positive surgical margin was 64%, whereas it was found 83% in those with negative surgical margin. As a consequence, positive surgical margin has shown to be an independent risk factor of PSA recurrence, with an emphasis on the importance of its prevalence and number (20) . One study showed a 10-year-survival rate of 88% in recurrent patients, while it was found 93% in those without recurrence, emphasizing that recurrence could be a sign for additional treatment (21) . However, publications pointing out the effect of PCM on metastatic progression and cancer-specific mortality are fairly not very consistent. Wright et al. reported in a study that the mortality risk due to prostate cancer was 1.7 times higher in patients with PCM than those without it (22) . Chalfie et al. suggested the adverse effect of PCM on survival in their study (23) , but they also noted that this effect was relatively low when compared to Gleason score and pathological stage.
In current studies, the relationship between prostate volume and PCM was evaluated for all surgical treatment methods of prostate cancer (2, 13, 24, 25) . In a study of Freedland et al., a number of 1602 patients who received open RP surgery were evaluated. In this study, the rate of high-grade disease was found to be significantly higher in those with lower prostate weight (with the risk being elevated by 7.61 times in patients with PV of 20 g compared to those with ≥100 g). Again, in this study, PCM was significantly higher in patients with lower PV (with the risk being elevated by 3.09 times in patients with PV of 20 g compared to those with ≥100 g). Furthermore, in this study, biochemical progression was found higher in patients with lower PV (with the risk being elevated by 3.94 times in patients with PV of 20 g compared to those with ≥100 g). When the study was evaluated; high-grade cancer, advanced disease and biochemical progression were all found significantly higher after RP in patients with lower PV, suggesting a possibly prognostic importance of PV on prostate cancer (2). Unlike our study, this study did not indicate a cut-off value for PV; various prostate volumes were rather compared. In a multicenter study of Patel VR et al., 6169 robotic RP patients due to prostate cancer were included in the study. This study investigated any relevant factors associated with PCM as well as its incidence in robotic RP. The rates for PCM in patients with T2 and T3 were found to be 9.5% and 37.2%, respectively. In multivariate analysis, pathological stage (4.588 times higher in patients with T3 than those of T2) and preoperative PSA (2.918 times higher in patients with PSA >10 ng/dl than those with ≤4) were found to be independent predictive factors for PCM in robotic RP. Again, this study demonstrated a correlation of increased PV with decreased PCM (24) . Similarly, elevated PSA levels and stage were found to be an independent predictive factor for PCM in our study. We also found that any value of PV under 34.5 cc was an independent predictive factor for PCM. In their study, Link BA et al. investigated whether the prostate weight had any effect on pathological and operative outcomes in 1847 patients who underwent robotic RP by 4 distinct surgeons. Prostate weights were classified as <30 g, 30 -49.9 g, 50 -69.9 g and 70 g ≤. In this study, the PCM rate was significantly higher in patients with lower PV (13) . Again, this study did not provide with a cutoff value for PV in determining PCM. Foley et al., in their study, evaluated the effects of prostate size on controlling cancer, continence and potency rates. A number of 440 patients who underwent open RP surgery were included in the study. The patients were divided into two groups, namely ≤ 75 g and > 75 g. The grade, tumor size and stage were found to be significantly lower in patients with > 75 g. Likewise; biochemical non-recurrence was significantly higher in patients with larger prostates (3). The presence of PCM does not only affect patients based on their oncologic outcomes, but also raises generalized anxiety and often increases the need for additional treatment (26) . Therefore, surgeons should make more of an effort to decrease the rates of positive surgical margins, while trying to maintain the quality of life of patients in terms of postoperative urinary and erectile function.
In general; the grade of disease, stage, biochemical progression and positivity for surgical margin tend to increase in patients with lower prostate volume. This is related to a deteriorated course of illness. The reason for increased positivity of surgical margin in those with lower prostate volume may be the challenge of distinguishing between prostatovesical and prostatourethral junctions.
In conclusion, we found that the prostate volume had an important role in positivity of surgical margins. It is likely that addition of prostate volume as well to nomograms used before surgery may be useful in improving of risk assessment in prostate cancer. Furthermore, evaluation of the prostate volume can be used as a prognostic factor for prostate cancer. Our study is a breakthrough in that it provides with a cutoff value in determining the positivity of surgical margins. Yet, further studies are needed with greater numbers of patients. 
